https://www.selleckchem.com/pr....oducts/pkm2-inhibito
in the development of sarcopenia in CD. Longitudinal studies investigating these factors are required. A systematic review was conducted to assess the effects of glutamine, arginine and omega-3 supplementation on the tolerance to treatment, nutritional status and immune function of head and neck cancer (HNC) patients undergoing chemoradiotherapy. Randomized clinical trials were searched in MEDLINE, EMBASE, CENTRAL, LILACS, ClinicalTrials.gov, OpenGrey and Proquest. Tolerance to treatment, nutritional status, immune fu
Curtir
Comentario
Compartilhar
